Nanalysis Scientific Corp. (NSCI.V)
| Previous Close | 0.5900 |
| Open | 0.5900 |
| Bid | 0.5800 x N/A |
| Ask | 0.6000 x N/A |
| Day's Range | 0.5900 - 0.5900 |
| 52 Week Range | 0.5600 - 1.4500 |
| Volume | |
| Avg. Volume | 37,512 |
| Market Cap | 55.591M |
| Beta (5Y Monthly) | 0.98 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0600 |
| Earnings Date | Nov 30, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 2.75 |
- CNW Group
Nanalysis Scientific Corp. to Participate in the Industrial Tech Virtual Conference Presented by Maxim Group LLC and Hosted by M-Vest
Nanalysis Scientific Corp. (TSXV:NSCI, OTCQX:NSCIF, FRA:1N1) ("Nanalysis" or the "Company") announces that Company CEO Sean Krakiwsky has been invited to present on the panel "Growing Opportunities in Industrial & Medical Markets" at the Industrial Tech Virtual Conference, presented by Maxim Group LLC and hosted by M-Vest, on Tuesday, March 21st 2023 at 1:00 p.m. ET.
- CNW Group
Nanalysis Scientific Corp. Announces Grant of Stock Options
Nanalysis Scientific Corp. (TSXV:NSCI, OTCQX:NSCIF, FRA:1N1) ("Nanalysis" or the "Company") announces that the Company's Board of Directors has granted 335,000 stock options to Directors and Officers of the Company, pursuant to the Company's stock option plan. Each option is exercisable to purchase one common share in the capital of the Company at $1.10 per share for a period of five years from the date of issuance. The options vest as to one-third on each of the 12 month, 24 month, and 36 month
- CNW Group
Nanalysis Announces Appointment of Randall McRae as CFO
Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in portable NMR machines and MRI technology for healthcare and industrial applications, announces the appointment of Randall McRae to Chief Financial Officer.
